Thus, reduced expression and frameshift mutations of ikzf1 in rag2:EGFP-CaMKII; tp53 mutant kidney marrow B lymphoblasts could lead to reduced productive VDJ recombination and thus inhibit B cell maturation, promoting leukemia. Here, TP53 is linked to leukemia.